Search Results - "Circulating tumor DNA"

Advances in CTC and ctDNA detection techniques: opportunities for improving breast cancer care.

Zhong HJ; State Key Laboratory of Bioactive Molecules and Druggability Assessment, International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development of Chinese Ministry of Education (MOE) of China, School of Pharmacy, Jinan University, Guangzhou, 510632, China. hjzhong@jnu.edu.cn., Zhen Y; State Key Laboratory of Bioactive Molecules and Druggability Assessment, International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development of Chinese Ministry of Education (MOE) of China, School of Pharmacy, Jinan University, Guangzhou, 510632, China., Chen S; State Key Laboratory of Bioactive Molecules and Druggability Assessment, International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development of Chinese Ministry of Education (MOE) of China, School of Pharmacy, Jinan University, Guangzhou, 510632, China., Shi W; Department of Oncology, The Second Affiliated Hospital of Anhui Medical University, Hefei, 230601, Anhui, China., Liang X; School of Arts and Sciences, Guangzhou Maritime University, Guangzhou, 510725, Guangdong, China. liangxxu@126.com., Yang GJ; State Key Laboratory for Managing Biotic and Chemical Threats to the Quality and Safety of Agro-Products, School of Marine Sciences, Ningbo University, Ningbo, 315211, Zhejiang, China. champion2014@126.com.

Journal Article; Review , 2025

An electrochemiluminescence biosensor based on metal porphyrin luminophore and covalent organic framework for the sensitive detection of ctDNA in non-small cell lung cancer.

Qing M; Chongqing Research Center for Pharmaceutical Engineering, College of Pharmacy, Chongqing Medical University, Chongqing, 400016, PR China., Fu L; Chongqing Research Center for Pharmaceutical Engineering, College of Pharmacy, Chongqing Medical University, Chongqing, 400016, PR China., Hu X; Chongqing Research Center for Pharmaceutical Engineering, College of Pharmacy, Chongqing Medical University, Chongqing, 400016, PR China., Mu Z; Chongqing Research Center for Pharmaceutical Engineering, College of Pharmacy, Chongqing Medical University, Chongqing, 400016, PR China., Wu Y; Chongqing Research Center for Pharmaceutical Engineering, College of Pharmacy, Chongqing Medical University, Chongqing, 400016, PR China., Bai L; Chongqing Research Center for Pharmaceutical Engineering, College of Pharmacy, Chongqing Medical University, Chongqing, 400016, PR China; Department of Respiratory and Critical Care Medicine, the First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, PR China. Electronic address: bailj1018@cqmu.edu.cn.

Journal Article , 2025

Circulating tumor DNA dynamic variation predicts sotorasib efficacy in KRASp.G12C-mutated advanced non-small cell lung cancer.

Passiglia F; Department of Oncology, University of Turin, S. Luigi Gonzaga Hospital-Orbassano, Turin, Italy., Pepe F; Department of Public Health, University Federico II of Naples, Naples, Italy., Russo G; Department of Public Health, University Federico II of Naples, Naples, Italy., Garbo E; Department of Oncology, University of Turin, S. Luigi Gonzaga Hospital-Orbassano, Turin, Italy., Listì A; Department of Oncology, University of Turin, S. Luigi Gonzaga Hospital-Orbassano, Turin, Italy., Benso F; Department of Oncology, University of Turin, S. Luigi Gonzaga Hospital-Orbassano, Turin, Italy., Scimone C; Department of Public Health, University Federico II of Naples, Naples, Italy., Palumbo L; Department of Public Health, University Federico II of Naples, Naples, Italy., Pluchino M; Department of Medicine and Surgery, University of Parma, Parma, Italy., Minari R; Medical Oncology Unit, University Hospital of Parma, Parma, Italy., Bordi P; Medical Oncology Unit, University Hospital of Parma, Parma, Italy., Cani M; Department of Oncology, University of Turin, S. Luigi Gonzaga Hospital-Orbassano, Turin, Italy., Ungaro A; Medical Oncology Unit, San Giuseppe Moscati Hospital, Taranto, Italy., Ambrogio C; Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center, University of Turin, Turin, Italy., Taulli R; Department of Oncology, University of Turin, S. Luigi Gonzaga Hospital-Orbassano, Turin, Italy., Capelletto E; Department of Oncology, University of Turin, S. Luigi Gonzaga Hospital-Orbassano, Turin, Italy., Balbi M; Department of Oncology, University of Turin, S. Luigi Gonzaga Hospital-Orbassano, Turin, Italy., Righi L; Department of Oncology, University of Turin, S. Luigi Gonzaga Hospital-Orbassano, Turin, Italy., Tiseo M; Department of Medicine and Surgery, University of Parma, Parma, Italy.; Medical Oncology Unit, University Hospital of Parma, Parma, Italy., Giannarelli D; IRCCS-Facility of Epidemiology and Biostatistics, Fondazione Policlinico Universitario A. Gemelli, Rome, Italy., Troncone G; Department of Public Health, University Federico II of Naples, Naples, Italy., Novello S; Department of Oncology, University of Turin, S. Luigi Gonzaga Hospital-Orbassano, Turin, Italy., Malapelle U; Department of Public Health, University Federico II of Naples, Naples, Italy.

Journal Article , 2025

[Molecular testing and liquid biopsies in colorectal cancer].

Stahler A; Med. Klinik m. S. Hämatologie, Onkologie und Tumorimmunologie (CCM), Charité Universitätsmedizin Berlin, Charitéplatz 1, 10117, Berlin, Deutschland. arndt.stahler@charite.de., Stintzing S; Med. Klinik m. S. Hämatologie, Onkologie und Tumorimmunologie (CCM), Charité Universitätsmedizin Berlin, Charitéplatz 1, 10117, Berlin, Deutschland.

English Abstract; Journal Article; Review , 2025

Molecular KRAS ctDNA Predicts Metastases and Survival in Pancreatic Cancer: A Prospective Cohort Study.

Leiting JL; Division of Hepatobiliary and Pancreas Surgery, Department of Surgery, Mayo Clinic, Rochester, MN, USA., Alva-Ruiz R; Division of Hepatobiliary and Pancreas Surgery, Department of Surgery, Mayo Clinic, Rochester, MN, USA., Yonkus JA; Division of Hepatobiliary and Pancreas Surgery, Department of Surgery, Mayo Clinic, Rochester, MN, USA., Abdelrahman AM; Division of Hepatobiliary and Pancreas Surgery, Department of Surgery, Mayo Clinic, Rochester, MN, USA., Lynch IT; Division of Hepatobiliary and Pancreas Surgery, Department of Surgery, Mayo Clinic, Rochester, MN, USA., Carlson DM; Division of Hepatobiliary and Pancreas Surgery, Department of Surgery, Mayo Clinic, Rochester, MN, USA., Carr RM; Department of Medical Oncology, Mayo Clinic, Rochester, MN, USA., Salomao DR; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA., McWilliams RR; Department of Medical Oncology, Mayo Clinic, Rochester, MN, USA., Starlinger PP; Division of Hepatobiliary and Pancreas Surgery, Department of Surgery, Mayo Clinic, Rochester, MN, USA., Thiels CA; Division of Hepatobiliary and Pancreas Surgery, Department of Surgery, Mayo Clinic, Rochester, MN, USA., Grotz TE; Division of Hepatobiliary and Pancreas Surgery, Department of Surgery, Mayo Clinic, Rochester, MN, USA., Warner SG; Division of Hepatobiliary and Pancreas Surgery, Department of Surgery, Mayo Clinic, Rochester, MN, USA., Cleary SP; Division of General Surgery, University of Toronto, Toronto, ON, Canada., Kendrick ML; Division of Hepatobiliary and Pancreas Surgery, Department of Surgery, Mayo Clinic, Rochester, MN, USA., Smoot RL; Division of Hepatobiliary and Pancreas Surgery, Department of Surgery, Mayo Clinic, Rochester, MN, USA., Kipp BR; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA., Truty MJ; Division of Hepatobiliary and Pancreas Surgery, Department of Surgery, Mayo Clinic, Rochester, MN, USA. truty.mark@mayo.edu.

Journal Article , 2025

A novel KRAS exon 2 drop-off digital PCR assay for mutation detection in cell-free DNA of cancer patients.

Addamo-De Nard B; Department of Medical Oncology and Hematology, University Hospital Zurich, Zurich, Switzerland., Geissmann M; Department of Medical Oncology and Hematology, University Hospital Zurich, Zurich, Switzerland., Akhoundova D; Department of Medical Oncology, Bern University Hospital, University of Bern, Bern, Switzerland., Pistoni C; Department of Medical Oncology and Hematology, University Hospital Zurich, Zurich, Switzerland.; University of Zurich, Zurich, Switzerland., Brezina T; Department of Medical Oncology and Hematology, University Hospital Zurich, Zurich, Switzerland., Zoche M; Institute of Pathology and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland., Weber A; Institute of Pathology and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland.; Institute of Molecular Cancer Research (IMCR), University of Zurich, Zurich, Switzerland., Hussung S; Department of Medical Oncology and Hematology, University Hospital Zurich, Zurich, Switzerland.; University of Zurich, Zurich, Switzerland., Fritsch R; Department of Medical Oncology and Hematology, University Hospital Zurich, Zurich, Switzerland. ralph.fritsch@usz.chRunning.; University of Zurich, Zurich, Switzerland. ralph.fritsch@usz.chRunning.; Comprehensive Cancer Center Zurich, Raemistrasse 100, Zurich, 8091, Switzerland. ralph.fritsch@usz.chRunning.

Journal Article , 2025

Liquid Biopsy in B and T Cell Lymphomas: From Bench to Bedside.

Almasri M; Division of Hematology, Department of Translational Medicine, Università del Piemonte Orientale and Azienda Ospedaliero-Universitaria Maggiore della Carità, 28100 Novara, Italy., Maher N; Division of Hematology, Department of Translational Medicine, Università del Piemonte Orientale and Azienda Ospedaliero-Universitaria Maggiore della Carità, 28100 Novara, Italy.; Division of Hematology, Department of Translational Medicine, Università del Piemonte Orientale and Azienda Ospedaliero-Universitaria di Alessandria, 56121 Alessandria, Italy., Al Deeban B; Division of Hematology, Department of Translational Medicine, Università del Piemonte Orientale and Azienda Ospedaliero-Universitaria Maggiore della Carità, 28100 Novara, Italy., Diop NM; Division of Hematology, Department of Translational Medicine, Università del Piemonte Orientale and Azienda Ospedaliero-Universitaria Maggiore della Carità, 28100 Novara, Italy., Moia R; Division of Hematology, Department of Translational Medicine, Università del Piemonte Orientale and Azienda Ospedaliero-Universitaria Maggiore della Carità, 28100 Novara, Italy., Gaidano G; Division of Hematology, Department of Translational Medicine, Università del Piemonte Orientale and Azienda Ospedaliero-Universitaria Maggiore della Carità, 28100 Novara, Italy.

Journal Article; Review , 2025

Clinical value of preoperative circulating tumor DNA before surgery in patients with esophageal squamous cell carcinoma.

Kobayashi R; Department of Surgery, Keio University School of Medicine, Tokyo, Japan., Matsuda S; Department of Surgery, Keio University School of Medicine, Tokyo, Japan. Electronic address: s.matsuda.a8@keio.jp., Nakamura K; Center for Cancer Genomics, Keio University School of Medicine, Tokyo, Japan., Kawakubo H; Department of Surgery, Keio University School of Medicine, Tokyo, Japan., Ho K; Department of Surgery, Keio University School of Medicine, Tokyo, Japan., Morimoto Y; Department of Surgery, Keio University School of Medicine, Tokyo, Japan., Hisaoka K; Department of Surgery, Keio University School of Medicine, Tokyo, Japan., Hoshi Y; Department of Surgery, Keio University School of Medicine, Tokyo, Japan., Takeuchi M; Department of Surgery, Keio University School of Medicine, Tokyo, Japan., Fukuda K; Department of Surgery, Keio University School of Medicine, Tokyo, Japan., Okui J; Department of Surgery, Keio University School of Medicine, Tokyo, Japan; Department of Preventive Medicine and Public Health, Keio University School of Medicine, Tokyo, Japan., Nishihara H; Center for Cancer Genomics, Keio University School of Medicine, Tokyo, Japan., Kitagawa Y; Department of Surgery, Keio University School of Medicine, Tokyo, Japan.

Journal Article , 2025

Performance Comparison of Droplet Digital PCR and Next-Generation Sequencing for Circulating Tumor DNA Detection in Non-Metastatic Rectal Cancer.

Szeto S; Applied Tumor Genomics Research Program, Research Program Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Kytölä S; Department of Genetics, HUS Diagnostic Center, Helsinki University Hospital, Helsinki, Finland.; Department of Genetics, University of Helsinki, Helsinki, Finland., Erkan EP; Applied Tumor Genomics Research Program, Research Program Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Centre, Tampere University Hospital, Tampere, Finland., Ahtiainen M; Department of Molecular Pathology, Central Finland Hospital Nova, Wellbeing Services County of Central Finland, Jyväskylä, Finland., Mecklin JP; Department of Education and Science, Central Finland Hospital Nova, Wellbeing Services County of Central Finland, Jyväskylä, Finland.; Faculty of Sports and Health Sciences, University of Jyväskylä, Jyväskylä, Finland., Kuopio T; Department of Molecular Pathology, Central Finland Hospital Nova, Wellbeing Services County of Central Finland, Jyväskylä, Finland.; Department of Biological and Environmental Science, University of Jyväskylä, Jyväskylä, Finland., Sallinen V; Department of Gastroenterological Surgery, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.; Transplantation and Liver Surgery, Helsinki University Hospital and University of Helsinki, Helsinki, Finland., Lepistö A; Department of Gastroenterological Surgery, Helsinki University Hospital and University of Helsinki, Helsinki, Finland., Koskenvuo L; Department of Gastroenterological Surgery, Helsinki University Hospital and University of Helsinki, Helsinki, Finland., Renkonen-Sinisalo L; Department of Gastroenterological Surgery, Helsinki University Hospital and University of Helsinki, Helsinki, Finland., Anttonen A; Department of Oncology, HUS Comprehensive Cancer Centre and University of Helsinki, Helsinki, Finland., Heiskala K; Department of Oncology, HUS Comprehensive Cancer Centre and University of Helsinki, Helsinki, Finland., Tulokas S; Department of Oncology, HUS Comprehensive Cancer Centre and University of Helsinki, Helsinki, Finland., Mäkelä S; Department of Oncology, HUS Comprehensive Cancer Centre and University of Helsinki, Helsinki, Finland., Wirta EV; Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Centre, Tampere University Hospital, Tampere, Finland.; Department of Gastroenterology and Alimentary Tract Surgery, Tampere University Hospital, Tampere, Finland., Tuunanen T; Department of Oncology, Tampere University Hospital, Tampere, Finland., Salminen T; Department of Oncology, Tampere University Hospital, Tampere, Finland., Ristimäki A; Applied Tumor Genomics Research Program, Research Program Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; Department of Pathology, HUS Diagnostic Center, Helsinki University Hospital, Helsinki, Finland., Seppälä TT; Applied Tumor Genomics Research Program, Research Program Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Centre, Tampere University Hospital, Tampere, Finland.; Department of Gastroenterology and Alimentary Tract Surgery, Tampere University Hospital, Tampere, Finland.

Journal Article; Comparative Study , 2025

Identification of minimal residual disease using the clonesight test for ultrasensitive ctDNA detection to anticipate late relapse in early breast cancer.

Comino-Méndez I; Medical Oncology Department, Hospital Universitario Virgen de la Victoria, 29010, Malaga, Spain. inaki.comino@ibima.eu.; The Biomedical Research Institute of Málaga, IBIMA-CIMES-UMA), 29010, Malaga, Spain. inaki.comino@ibima.eu.; Centro de Investigación Biomédica en Red de Cancer (CIBERONC - CB16, 12/00481), 28029, Madrid, Spain. inaki.comino@ibima.eu., Velasco-Suelto J; Medical Oncology Department, Hospital Universitario Virgen de la Victoria, 29010, Malaga, Spain.; The Biomedical Research Institute of Málaga, IBIMA-CIMES-UMA), 29010, Malaga, Spain.; Centro de Investigación Biomédica en Red de Cancer (CIBERONC - CB16, 12/00481), 28029, Madrid, Spain., Pascual J; Medical Oncology Department, Hospital Universitario Virgen de la Victoria, 29010, Malaga, Spain.; The Biomedical Research Institute of Málaga, IBIMA-CIMES-UMA), 29010, Malaga, Spain.; Centro de Investigación Biomédica en Red de Cancer (CIBERONC - CB16, 12/00481), 28029, Madrid, Spain., López-López E; Medical Oncology Department, Hospital Universitario Virgen de la Victoria, 29010, Malaga, Spain.; The Biomedical Research Institute of Málaga, IBIMA-CIMES-UMA), 29010, Malaga, Spain., Quirós-Ortega ME; Medical Oncology Department, Hospital Universitario Virgen de la Victoria, 29010, Malaga, Spain.; The Biomedical Research Institute of Málaga, IBIMA-CIMES-UMA), 29010, Malaga, Spain.; Centro de Investigación Biomédica en Red de Cancer (CIBERONC - CB16, 12/00481), 28029, Madrid, Spain., Gaona-Romero C; Medical Oncology Department, Hospital Universitario Virgen de la Victoria, 29010, Malaga, Spain.; The Biomedical Research Institute of Málaga, IBIMA-CIMES-UMA), 29010, Malaga, Spain., Martín-Muñoz A; Hematological Malignancies Clinical Research Unit, Centro Nacional de Investigaciones Oncologicas (CNIO), Madrid, Spain.; Altum Sequencing Co, Madrid, Spain., Losana P; Altum Sequencing Co, Madrid, Spain., Heredia Y; Altum Sequencing Co, Madrid, Spain., Alba E; Medical Oncology Department, Hospital Universitario Virgen de la Victoria, 29010, Malaga, Spain.; The Biomedical Research Institute of Málaga, IBIMA-CIMES-UMA), 29010, Malaga, Spain.; Centro de Investigación Biomédica en Red de Cancer (CIBERONC - CB16, 12/00481), 28029, Madrid, Spain.; Faculty of Medicine, University of Málaga, 29010, Malaga, Spain., Guerrero-Zotano A; Medical Oncology Department, Fundación Instituto Valenciano de Oncología, Valencia, Spain. angel.guerrero.zotano@gmail.com.

Journal Article , 2025

Clinical Implications of Circulating Tumor DNA in Multiple Myeloma and Its Precursor Diseases.

Park SS; Department of Hematology, Seoul St. Mary's Hematology Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.; Catholic Research Network for Multiple Myeloma, Catholic Hematology Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea., Kim NY; Department of Medical Sciences, Graduate School of The Catholic University of Korea, Seoul, Korea., Lim JY; Department of Hematology, Seoul St. Mary's Hematology Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.; Catholic Research Network for Multiple Myeloma, Catholic Hematology Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea., Lee JY; Department of Hematology, Seoul St. Mary's Hematology Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.; Catholic Research Network for Multiple Myeloma, Catholic Hematology Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea., Yun S; Department of Medical Sciences, Graduate School of The Catholic University of Korea, Seoul, Korea., Chung YJ; Department of Medical Sciences, Graduate School of The Catholic University of Korea, Seoul, Korea.; Department of Microbiology, College of Medicine, The Catholic University of Korea, Seoul, Korea.; Catholic Research Institute for Human Genome Polymorphism, Precision Medicine Research Center, College of Medicine, The Catholic University of Korea; Seoul, Korea., Jung SH; Department of Medical Sciences, Graduate School of The Catholic University of Korea, Seoul, Korea.; Catholic Research Institute for Human Genome Polymorphism, Precision Medicine Research Center, College of Medicine, The Catholic University of Korea; Seoul, Korea.; Department of Biochemistry, College of Medicine, The Catholic University of Korea, Seoul, Korea., Min CK; Department of Hematology, Seoul St. Mary's Hematology Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.; Catholic Research Network for Multiple Myeloma, Catholic Hematology Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.

Journal Article , 2025

A prospective study of methylated ctDNA in patients undergoing treatment for liver metastases from colorectal cancer.

Raunkilde L; Department of Oncology, Vejle Hospital, University Hospital of Southern Denmark, Beriderbakken 4, 7100, Vejle, Denmark; Danish Colorectal Cancer Center South, Vejle Hospital, Beriderbakken 4, 7100, Vejle, Denmark; Department of Regional Health Research, University of Southern Denmark, Campusvej 55, 5230, Odense M, Denmark. Electronic address: Louise.raunkilde.larsen@rsyd.dk., Andersen RF; Department of Oncology, Vejle Hospital, University Hospital of Southern Denmark, Beriderbakken 4, 7100, Vejle, Denmark; Danish Colorectal Cancer Center South, Vejle Hospital, Beriderbakken 4, 7100, Vejle, Denmark; Department of Clinical Biochemistry and Immunology, Vejle Hospital, University Hospital of Southern Denmark, Beriderbakken 4, 7100, Vejle, Denmark., Thomsen CB; Department of Oncology, Vejle Hospital, University Hospital of Southern Denmark, Beriderbakken 4, 7100, Vejle, Denmark; Danish Colorectal Cancer Center South, Vejle Hospital, Beriderbakken 4, 7100, Vejle, Denmark., Hansen TF; Department of Oncology, Vejle Hospital, University Hospital of Southern Denmark, Beriderbakken 4, 7100, Vejle, Denmark; Danish Colorectal Cancer Center South, Vejle Hospital, Beriderbakken 4, 7100, Vejle, Denmark; Department of Regional Health Research, University of Southern Denmark, Campusvej 55, 5230, Odense M, Denmark., Jensen LH; Department of Oncology, Vejle Hospital, University Hospital of Southern Denmark, Beriderbakken 4, 7100, Vejle, Denmark; Danish Colorectal Cancer Center South, Vejle Hospital, Beriderbakken 4, 7100, Vejle, Denmark; Department of Regional Health Research, University of Southern Denmark, Campusvej 55, 5230, Odense M, Denmark.

Journal Article; Observational Study , 2025

Prognostic significance of circulating tumor DNA in urothelial carcinoma patients undergoing immune checkpoint inhibitor therapy: a systematic review and meta-analysis.

Ma Q; Shandong Provincial Third Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.; Department of Hyperbaric Oxygen, Shandong Provincial Third Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China., Hou S; Department of Gastrointestinal Surgery, Central Hospital Affiliated to Shandong First Medical University, Jinan, China., Ma H; Shandong Provincial Third Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.; Department of Neurology, Shandong Provincial Third Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China., Gao J; Shandong Provincial Third Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China., Song D; Shandong Provincial Third Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.; Department of Neurology, Shandong Provincial Third Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.

Journal Article; Systematic Review; Meta-Analysis , 2025

The biological and technical challenges facing utilizing circulating tumor DNA in non-metastatic breast cancer patients.

Zeng Z; Department of Radiation and Medical Oncology, Hubei Key Laboratory of Tumor Biological Behaviors, Hubei Cancer Clinical Study Center, Zhongnan Hospital of Wuhan University, 430071, Wuhan, China., Yi Z; Department of Radiation and Medical Oncology, Hubei Key Laboratory of Tumor Biological Behaviors, Hubei Cancer Clinical Study Center, Zhongnan Hospital of Wuhan University, 430071, Wuhan, China. Electronic address: yizongbi@163.com., Xu B; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 100021, Beijing, China. Electronic address: xubh@cicams.ac.cn.

Journal Article; Review , 2025

Deep targeted sequencing of circulating tumor DNA to inform treatment in patients with metastatic castration-resistant prostate cancer.

Nørgaard M; Department of Molecular Medicine, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, Aarhus, 8200, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark., Rusan M; Department of Molecular Medicine, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, Aarhus, 8200, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.; Department of Clinical Pharmacology, Aarhus University Hospital, Aarhus, Denmark., Kondrup K; Department of Molecular Medicine, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, Aarhus, 8200, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark., Sørensen EMG; Department of Molecular Medicine, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, Aarhus, 8200, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark., Weiss S; Department of Molecular Medicine, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, Aarhus, 8200, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark., Bjerre MT; Department of Molecular Medicine, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, Aarhus, 8200, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.; Department of Urology, Aarhus University Hospital, Aarhus, Denmark.; Department of Urology, Gødstrup Hospital, Gødstrup, Denmark., Fredsøe J; Department of Molecular Medicine, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, Aarhus, 8200, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark., Vang S; Department of Molecular Medicine, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, Aarhus, 8200, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark., Jensen JB; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.; Department of Urology, Gødstrup Hospital, Gødstrup, Denmark., De Laere B; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.; Department of Human Structure and Repair, Ghent University, Ghent, Belgium.; Cancer Research Institute Gent (CRIG), Ghent University, Ghent, Belgium., Grönberg H; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden., Borre M; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.; Department of Urology, Aarhus University Hospital, Aarhus, Denmark., Lindberg J; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden., Sørensen KD; Department of Molecular Medicine, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, Aarhus, 8200, Denmark. kdso@clin.au.dk.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark. kdso@clin.au.dk.

Journal Article , 2025

Optimization of bile preparation for liquid biopsy in cholangiocarcinoma focusing on circulating tumor DNA and protein stability.

Han JY; Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, Keimyung University Dongsan Medical Center, Daegu, Republic of Korea., Ahn KS; Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, Keimyung University Dongsan Medical Center, Daegu, Republic of Korea. ahnks@dsmc.or.kr., Kim MJ; Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, Keimyung University Dongsan Medical Center, Daegu, Republic of Korea., Kim TS; Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, Keimyung University Dongsan Medical Center, Daegu, Republic of Korea., Kim YH; Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, Keimyung University Dongsan Medical Center, Daegu, Republic of Korea., Cho KB; Division of Gastroenterology, Department of Internal Medicine, Keimyung University Dongsan Medical Center, Daegu, Republic of Korea., Kang KJ; Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, Keimyung University Dongsan Medical Center, Daegu, Republic of Korea.

Journal Article , 2025

Circulating tumor DNA- and cancer tissue-based next-generation sequencing reveals comparable consistency in targeted gene mutations for advanced or metastatic non-small cell lung cancer.

Huang W; Lung Cancer Center/Lung Cancer Institute, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China.; Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China., Xu K; Lung Cancer Center/Lung Cancer Institute, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China.; Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China., Liu Z; Lung Cancer Center/Lung Cancer Institute, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China.; Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China., Wang Y; Lung Cancer Center/Lung Cancer Institute, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China.; Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China., Chen Z; Lung Cancer Center/Lung Cancer Institute, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China.; Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China., Gao Y; Department of General Thoracic Surgery, Inselspital, Bern University Hospital, University of Bern, Bern 3010, Switzerland.; Department for BioMedical Research, University of Bern, Bern 3010, Switzerland., Peng R; Department of General Thoracic Surgery, Inselspital, Bern University Hospital, University of Bern, Bern 3010, Switzerland.; Department for BioMedical Research, University of Bern, Bern 3010, Switzerland., Zhou Q; Lung Cancer Center/Lung Cancer Institute, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China.; Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China.

Journal Article , 2025

Whole-genome sequencing of cell-free DNA reveals DNA of tumor origin in plasma from patients with colorectal adenomas.

Frydendahl A; Department of Molecular Medicine, Aarhus University Hospital, Denmark.; Department of Clinical Medicine, Aarhus University, Denmark., Widman AJ; Memorial Sloan Kettering Cancer Center, New York, NY, USA.; New York Genome Center, New York, NY, USA., Øgaard N; Department of Molecular Medicine, Aarhus University Hospital, Denmark.; Department of Clinical Medicine, Aarhus University, Denmark., Arora A; New York Genome Center, New York, NY, USA., Halmos D; New York Genome Center, New York, NY, USA.; Weill Cornell Medicine, New York, NY, USA., Nors J; Department of Molecular Medicine, Aarhus University Hospital, Denmark.; Department of Clinical Medicine, Aarhus University, Denmark., Ahrenfeldt J; Department of Molecular Medicine, Aarhus University Hospital, Denmark.; Department of Clinical Medicine, Aarhus University, Denmark., Henriksen TV; Department of Molecular Medicine, Aarhus University Hospital, Denmark.; Department of Clinical Medicine, Aarhus University, Denmark., Demuth C; Department of Molecular Medicine, Aarhus University Hospital, Denmark.; Department of Clinical Medicine, Aarhus University, Denmark., Raaby L; Department of Molecular Medicine, Aarhus University Hospital, Denmark.; Department of Clinical Medicine, Aarhus University, Denmark.; Department of Pathology, Aarhus University Hospital, Denmark., Rasmussen MH; Department of Molecular Medicine, Aarhus University Hospital, Denmark.; Department of Clinical Medicine, Aarhus University, Denmark., Therkildsen C; Gastro Unit, Copenhagen University Hospital, Amager - Hvidovre Hospital, Hvidovre, Denmark., Landau DA; New York Genome Center, New York, NY, USA.; Weill Cornell Medicine, New York, NY, USA., Andersen CL; Department of Molecular Medicine, Aarhus University Hospital, Denmark.; Department of Clinical Medicine, Aarhus University, Denmark.

Journal Article , 2025

Genomic correlates of response and resistance to the irreversible FGFR1-4 inhibitor futibatinib based on biopsy and circulating tumor DNA profiling.

Goyal L; Department of Medicine, Stanford Cancer Center, Stanford University School of Medicine, Palo Alto, USA; Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, USA. Electronic address: lgoyal@stanford.edu., DiToro D; Brigham and Women's Hospital, Boston, USA., Hollebecque A; Département d'Innovation Thérapeutique et Essais Précoces (DITEP), Gustave Roussy, F-94805, VILLEJUIF, France., Bridgewater JA; University College London Cancer Institute, University College London, London, UK., Shimura M; Taiho Oncology, Inc., Princeton, USA., Kano A; Taiho Oncology, Inc., Princeton, USA., Okamura S; Taiho Oncology, Inc., Princeton, USA., Silhavy JL; Illumina, Inc., San Diego, USA., Wacheck V; Taiho Oncology, Inc., Princeton, USA., Halim A; Taiho Oncology, Inc., Princeton, USA., Meric-Bernstam F; The University of Texas MD Anderson Cancer Center, Houston, USA.

Journal Article; Clinical Trial, Phase I; Clinical Trial, Phase II , 2025

Tetrahedral DNA nanostructures-assisted electrochemical assay for detecting circulating tumor DNA by combining a masking tactic with 3D-hybridization chain reactions.

Duan X; Key Laboratory of Microbiological Metrology, Measurement & Bio-product Quality Security , State Administration for Market Regulation, College of Life Science, China Jiliang University, Hangzhou, 310018, China., Qin W; Key Laboratory of Microbiological Metrology, Measurement & Bio-product Quality Security , State Administration for Market Regulation, College of Life Science, China Jiliang University, Hangzhou, 310018, China. Electronic address: wwqinsinap@163.com., Hao J; Key Laboratory of Microbiological Metrology, Measurement & Bio-product Quality Security , State Administration for Market Regulation, College of Life Science, China Jiliang University, Hangzhou, 310018, China., Wang J; Key Laboratory of Microbiological Metrology, Measurement & Bio-product Quality Security , State Administration for Market Regulation, College of Life Science, China Jiliang University, Hangzhou, 310018, China., Qiu Y; Key Laboratory of Microbiological Metrology, Measurement & Bio-product Quality Security , State Administration for Market Regulation, College of Life Science, China Jiliang University, Hangzhou, 310018, China., ShenTu X; Key Laboratory of Microbiological Metrology, Measurement & Bio-product Quality Security , State Administration for Market Regulation, College of Life Science, China Jiliang University, Hangzhou, 310018, China., Ye Z; Key Laboratory of Microbiological Metrology, Measurement & Bio-product Quality Security , State Administration for Market Regulation, College of Life Science, China Jiliang University, Hangzhou, 310018, China., Yu X; Key Laboratory of Microbiological Metrology, Measurement & Bio-product Quality Security , State Administration for Market Regulation, College of Life Science, China Jiliang University, Hangzhou, 310018, China. Electronic address: yxp@cjlu.edu.cn.

Journal Article , 2025